• Pronto intervento 800 900 999
  • Italiano ( Italian )

Results and presentations

We present here all the documentation relating to results and strategic plans since our return to the stock market in 2016, as well as the listing documents.

2024 Quarter Results

  • Press release
  • Presentation
  • Half-year financial report

Shareholders' Meeting

2023 quarter results, iii quarter.

  • 2023 Integrated Annual Report – format ESEF Zip
  • 2023 Integrated Annual Report – format PDF

2023-2029 Strategic Plan

  • Video 2023-2029 Strategic Plan

The journey continues: Sustainable Value Creation Plan and TCFD report

  • Sustainable Value Creation Plan 2023-2029
  • 2022 – 2023 Driving innovation for energy transition – TCFD Report

2022 Quarter Results

  • 2022 Integrated Annual Report – format ESEF Zip
  • 2022 Integrated Annual Report – format PDF
  • Integrated Annual Online Report 

2022-2028 Strategic Plan

  • Video 2022-2028 Strategic Plan

Builders of the Future: Sustainable Value Creation Plan and TCFD report

  • Sustainable Value Creation Plan 2022-2028
  • 2021 Driving innovation for energy transition – TCFD report

2021 Quarter Results

  • Integrated Annual Report – format ESEF Zip
  • Integrated Annual Report – format PDF

2021-2027 Strategic Plan

  • Video 2021-2027 Strategic Plan
  • Video 2021-2027 Strategic Plan – interview

Update on DEPA Infrastructure Acquisition

2020 quarter results.

  • Integrated annual report
  • Integrated annual online report 

2020-2026 Strategic Plan

  • Video 2020-2026 Strategic Plan

Shareholders’ Meeting

Performance update, 2019 quarter results.

  • Financial report
  • Financial online report

2019-2025 Strategic Plan

  • Video 2019-2025 Strategic Plan
  • Video 2019-2025 Strategic Plan – interview
  • Video Shareholders’ Meeting

Non-Financial Statement 2019

  • Non-Financial Statement
  • Non-Financial Statement online report

2018 Quarter Results

  • Financial online report 

2018-2024 Strategic Plan

  • Video 2018-2024 Strategic Plan
  • Video Shareholders’ Meeting

Non-Financial Statement 2018

Investor day, 2017 quarter results.

Last update:  12 September, 2024 - 4:26 pm

roche investor presentation 2021

  • Market data
  • Connectivity
  • News and events

Investor Relations

Connect to moex products for business.

Moscow Exchange operates Russia's largest public trading markets for equity, fixed income, derivative, foreign exchange and money market products as well as Russia's Central Securities Depository (CSD) and the country's largest clearing service provider, National Clearing Centre.  It also provides information services relating to the Russian securities market as well as software solutions and other technology services. In 2018 it ranked among the world's top-25 exchanges for equity trading by value traded and among top-ten exchanges for exchange-traded derivatives by number of contracts traded. It also was the third among global exchanges in bond trading (by value traded).  

The Moscow Exchange was formed in December 2011 as a result of a merger between Russia's two main exchange groups.  The merger brought together MICEX Group, the oldest domestic exchange and operator of the leading securities, foreign exchange and money market platform in Russia, and the RTS Group, at the time the operator of Russia's leading derivatives market. This combination created a vertically integrated public trading market across most major asset classes. Following the merger the Company became an open joint stock company (OJSC) and was named Moscow Exchange.

The Moscow Exchange operates Russia's largest public trading markets for equity, bonds, derivatives, foreign exchange and money market products as well as Russia's Central Securities Depository (CSD) and the country's largest clearing service provider, National Clearing Centre. It also provides information services relating to the Russian securities market as well as software solutions and other technology services to its members. In the year ended 31 December 2012, it ranked among the world's top-20 exchanges for equity trading by market capitalisation and among the top-ten exchanges for bond trading by trading volume (by value) and for exchange-traded derivatives by number of contracts traded. Moscow Exchange has 694 companies listed on its securities exchange, as at 31 December 2012, including many of Russia's largest companies.  

The Moscow Exchange was formed in December 2011 as a result of a merger between Russia's two main exchange groups.  The merger brought together MICEX Group, the oldest domestic exchange and operator of the leading securities, foreign exchange and money market platform in Russia, and the RTS Group, at the time the operator of Russia's leading derivatives market. This combination created a vertically integrated public trading market across most major asset classes. Following the merger the Company became an open joint stock company (OJSC) and was named Moscow Exchange.

 
 
 
 

INVESTOR CALENDAR

Wood's Emerging Europe Conference, Prague
UBS GEM Conference, New York, Boston

QUICK LINKS

  • Financial statements
  • Frequently asked questions
  • Stock Information
  • Monthly newsletters

ANNUAL REPORTS

  • Annual report 2013
  • Interactive Annual Report for 2012

TRADING VOLUMES

  • Moscow Exchange Group Markets Statistics
  • Quick Analyzer
  • Sergey Klinkov Phone: +7 (495) 363-3232, +7 (495) 232-0555 Fax: +7 (495) 705-9622 e-mail : [email protected] Address: 125009 Moscow, Bolshoy Kislovsky per, 13

COMING EVENTS

  • Annual Report 2022
  • Sustainability Report 2022
  • Annual Report 2021
  • Sustainability Report 2021

Anton Terentiev Head of investor relations

  • Phone: +7 (495) 363-3232, Fax: +7 (495) 705-9622 e-mail : [email protected] Address: 125009 Moscow, Bolshoy Kislovsky per, 13

roche investor presentation 2021

2021 Investment Banking Off-cycle Internship (Moscow)

Placement and duration

The Investment Banking Off-cycle Internship is an opportunity to experience the culture and atmosphere in the Investment Banking Division (IBD) by taking on some of the responsibilities and functions of a Full-time Analyst for a short period. The internship typically lasts three to six months, but can vary in length depending on business needs and candidate availability. You will spend your internship assigned to a specific group in a specific region, building basic skills in financial analysis, accounting and valuation, while working on a wide range of domestic and international transactions.

Training program

You will receive on-the-job training and benefit from working alongside experienced professionals on a variety of projects.

Responsibilities

Gathering and synthesising financial and operating information about companies, industries and governments.

Creating and updating financial models.

Gathering market data to analyse trends and help value and price transactions.

Drafting presentations and memoranda for a wider audience within the Firm and the financial services industry.

Attending team discussions and client meetings, where you may be asked to deliver parts of a presentation.

Qualifications/ Skills/ Requirements

You have strong analytical and numerical skills that put You at ease with financial data.

You are results-driven, and perform well under pressure and against tight deadlines.

You are a proven team player and can manage a wide range of responsibilities.

You have an excellent academic background and fluency in English.

Ability to communicate effectively in multiple languages is an advantage.

You articulate complex ideas simply and summarise them effectively.

You are committed to excellence in your work and maintain high professional and ethical standards.

*Salary is competitive with excellent benefits.

This Program is closed to applications.

  • About Roche
  • Sustainability
  • Focus areas
  • Pharma solutions
  • Diagnostic solutions
  • Team & structure
  • Innovation process
  • Ethical standards

Roche’s Virtual Investor Event at EASD

Webinar replay.

Please register to access the replay of the webcast*

Check out the

Discover more

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.

IMAGES

  1. Roche Holding (RHHBY) Investor Presentation

    roche investor presentation 2021

  2. Roche Stock (RHHBF) Faces Challenges But Could Still Be Perfect For

    roche investor presentation 2021

  3. Roche Investor Funding Elevator Pitch Deck Ppt Template PPT Sample

    roche investor presentation 2021

  4. Financial Projections Roche Investor Funding Elevator Pitch Deck PPT

    roche investor presentation 2021

  5. Roche Investor Funding Elevator Pitch Deck Ppt Template PPT Sample

    roche investor presentation 2021

  6. Roche Investor Funding Elevator Pitch Deck Ppt Template PPT Sample

    roche investor presentation 2021

VIDEO

  1. Ackman: The Economy Is Stronger Than People Think

  2. Bill Ackman On The Longer-term Risks Facing The Economy #economy #investing #shorts

  3. Roche Presentation

  4. GAMCO Natural Resources, Gold &Income Trust (GNT) Vincent Roche, Portfolio Manager

  5. Disclosure Initiative–Subsidiaries without Public Accountability: Disclosures

  6. Fondation Roche : présentation

COMMENTS

  1. Reporting

    Reporting scope. We provide integrated information about Roche's financial and non-financial performance in our as well as in our and cover all regions and divisions from 1 January to 31 December 2023. The reporting scope is defined and outlined in our Finance Report and there have been no significant changes in scope in 2023 compared to 2022.

  2. Roche Annual Report 2021

    Dear Shareholders, Since its founding 125 years ago, Roche has worked to improve the health and lives of countless people all over the world. Our anniversary year was no exception: In 2021 our more than 100,000 employees and our partners developed, manufactured and provided global access to state-of-the-art diagnostics and treatments for serious diseases, particularly for COVID-19.

  3. Investor downloads

    Access Roche's financial and non-financial presentations archived as downloads.

  4. PDF Finance Report 2021

    Finance Report 2021 Roche Group 1 Finance - 2021 in Brief Roche in 2021 The Roche Group reported strong overall results in 2021, with the underlying business showing resilience in the continuing pandemic environment. Sales grew by 9% at constant exchange rates (CER). IFRS net income increased by 2% (CER) and core earnings per

  5. PDF Annual Report 2021

    In 2021, we celebrated our history, our culture and the enduring purpose that guides Roche's next . 125 years towards a sustainable, healthy future. ... the 100,000 employees who work at Roche. I don't feel like an investor for myself. I see myself as someone who prepares the company for the next generation. J. Duschmalé: I see it very ...

  6. PDF Investor Update

    Investor Update F. Hoffmann-La Roche Ltd 4070 Basel Switzerland Investor Relations email: [email protected] Tel. +41 61 68-88880 Fax +41 61 69-10014 www.roche.com 1/11 Ad hoc announcement pursuant to Art. 53 LR Basel, 22 July 2021 Roche reports good half-year results

  7. PDF Roche

    Roche YTD September 2021 sales Basel, 20 October 2021. This presentation contains certain forward-looking statements. These forward-looking statements may be identified by words such as 'believes', 'expects', 'anticipates', 'projects', 'intends', 'should', 'seeks', 'estimates', 'future' or similar expressions ...

  8. PDF Digitalization along the value chain Investor Relations Event ...

    Digitalization along the value chain. Investor Relations Event 17 November 2021. This presentation contains certain forward-looking statements. These forward-looking statements may be identified by words such as 'believes', 'expects', 'anticipates', 'projects', 'intends', 'should', 'seeks', 'estimates', 'future ...

  9. Investors

    Investors. Friday, 13 September 2024 at 16.00 CEST. Monday, 30 September 2024 at 9:00am BST. Investor updates. Upcoming Investor events. View all eventsRoche's Virtual Investor Event at EASDNephron Napa SummitRoche's Pharma Day 2024Roche Diagnostics newsRoche at a glance. Investor relations team contacts. Discover more.

  10. PDF Investor Update

    Investor Update F. Hoffmann-La Roche Ltd 4070 Basel Switzerland Investor Relations email: [email protected] Tel. +41 61 68-88880 Fax +41 61 69-10014 www.roche.com 1/14 Ad hoc announcement pursuant to Art. 53 LR Basel, 3 February 2022 Roche reports good results in 2021 1Group sales increase 9% at constant exchange rates ...

  11. PDF This presentation contains certain forward-looking statements ...

    This presentation contains certain forward-looking statements. These forward-looking statements may be identified by words such ... Any statements regarding earnings per share growth is not a profit forecast and should not be interpreted to mean that Roche's earnings or earnings ... 2021 vs. 2020 2022 vs. 2021 2021 vs. 2020 2022 vs. 2021 Pharma

  12. Reports and presentations

    Reports and presentations We present here all the documentation relating to results and strategic plans since our return to the stock market in 2016, as well as the listing documents. 2024 2023 2022 2021 2020 2019 2018 2017 Quotazione in borsa

  13. Roche's Full-Year Results 2021

    Investors; Careers; Roche's Full-Year Results 2021 Roche has published its Full Year results for 2021 prior to the opening of the Swiss Stock Exchange on Thursday, 3rd February 2022. ... Check out the. Downloads Investor update Presentation Presentation with appendix

  14. PDF Annual Report 2022

    Roche is being led into the future by a strong and highly experienced team. * Unless otherwise stated, all growth rates and comparisons to the previous year are at constant exchange rates (CER; average rates 2021) and all total figures quoted are reported in CHF. Chairman's shareholder letter | Roche 9

  15. Presentations

    4Q 2023 Earnings presentation 3Q 2023 Earnings presentation MOEX Strategy 2028 webcast transcript Webcast recording on MOEX Strategy 2028 2Q 2023 Earnings presentation 1Q 2023 Earnings presentation 4Q 2022 Earnings presentation 3Q 2022 Earnings presentation 2Q 2022 Earnings presentation Investor presentation, March 2022 Investor presentation, February 2022 Investor presentation, January 2022 ...

  16. Investor Relations

    Investor Relations. Moscow Exchange operates Russia"s largest public trading markets for equity, fixed income, derivative, foreign exchange and money market products as well as Russia"s Central Securities Depository (CSD) and the country"s largest clearing service provider, National Clearing Centre. It also provides information services relating to the Russian securities market as well as ...

  17. PDF Investor Update

    Investor Update F. Hoffmann-La Roche Ltd 4070 Basel Switzerland Investor Relations email: [email protected] Tel. +41 61 68-88880 Fax +41 61 69-10014 www.roche.com ... January - June 2022 2022 2021 CER CHF Group sales 32,295 30,713 5 5 Pharmaceuticals Division 22,347 21,671 3 3 ...

  18. Roche Diagnostics Investor Day 2021

    Roche Diagnostics Investor Day 2021 Roche has hosted a virtual event on Tuesday, 23rd March 2021 The event addressed the following topics. Diagnostics market opportunities, strategy and organisation. ... Presentation Presentation - Interactive slide deck Discover more.

  19. 2021 Investment Banking Off-cycle Internship (Moscow)

    The Investment Banking Off-cycle Internship is an opportunity to experience the culture and atmosphere in the Investment Banking Division (IBD) by taking on some of the responsibilities and functions of a Full-time Analyst for a short period. The internship typically lasts three to six months, but can vary in length depending on business needs ...

  20. Roche

    Discover how Roche made an impact in 2023. Discover our innovative journey in revolutionising patient care and how we've impacted millions worldwide. Explore our Annual Report to see our strides in pharmaceuticals and diagnostics. Roche Group sales: CHF 58.7 billion. Pharmaceuticals Division sales: CHF 44.6 billion.

  21. Roche

    Access the Roche webcast replay of Roche's Virtual Investor Event at EASD. ... Presentation Invitation Discover more. This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not ...